Literature DB >> 24111939

Characterization of UV-screening compounds, mycosporine-like amino acids, and scytonemin in the cyanobacterium Lyngbya sp. CU2555.

Rajesh P Rastogi1, Aran Incharoensakdi.   

Abstract

Ultraviolet-screening compounds from the cyanobacterium Lyngbya sp. CU2555 were partially characterized and investigated for their induction by UV radiation, stability under different abiotic factors, and free radical scavenging activity. Based on the high-performance liquid chromatography coupled with diode array detector and ion trap liquid chromatography/mass spectrometry analysis, the compounds were identified as palythine (UVλ max: 319 nm; m/z: 245), asterina (UVλ max: 330 nm; m/z: 289), scytonemin (UVλ max: 384 nm; mw: 544), and reduced scytonemin (UVλ max: 384 nm; m/z: 547). This is the first report for the occurrence of palythine, asterina, and an unknown mycosporine-like amino acids (MAA), M-312 (UVλ max: 312 ± 1 nm), in addition to scytonemin and reduced scytonemin in Lyngbya strains studied so far. Induction of MAAs and scytonemin was significantly more prominent upon exposure to UV-A + UV-B radiation. Both MAAs and scytonemin were highly resistant to some physicochemical factors such as UV-B, heat, and a strong oxidizing agent and exhibited strong antioxidant activity. These results indicate that the studied cyanobacterium may protect itself from deleterious short-wavelength radiation by synthesizing photoprotective compounds in response to harmful UV radiation.
© 2013 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  UV-induced production; cyanobacteria; mycosporine-like amino acids; photoprotection; scytonemin

Mesh:

Substances:

Year:  2013        PMID: 24111939     DOI: 10.1111/1574-6941.12220

Source DB:  PubMed          Journal:  FEMS Microbiol Ecol        ISSN: 0168-6496            Impact factor:   4.194


  24 in total

1.  Comparative Profiling and Discovery of Novel Glycosylated Mycosporine-Like Amino Acids in Two Strains of the Cyanobacterium Scytonema cf. crispum.

Authors:  Paul M D'Agostino; Vivek S Javalkote; Rabia Mazmouz; Russell Pickford; Pravin R Puranik; Brett A Neilan
Journal:  Appl Environ Microbiol       Date:  2016-09-16       Impact factor: 4.792

2.  Scytonemin Plays a Potential Role in Stabilizing the Exopolysaccharidic Matrix in Terrestrial Cyanobacteria.

Authors:  Xiang Gao
Journal:  Microb Ecol       Date:  2016-09-13       Impact factor: 4.552

3.  Naturally occurring fluorescence protects the eutardigrade Paramacrobiotus sp. from ultraviolet radiation.

Authors:  Harikumar R Suma; Swathi Prakash; Sandeep M Eswarappa
Journal:  Biol Lett       Date:  2020-10-14       Impact factor: 3.703

Review 4.  Cyanobacteria-From the Oceans to the Potential Biotechnological and Biomedical Applications.

Authors:  Shaden A M Khalifa; Eslam S Shedid; Essa M Saied; Amir Reza Jassbi; Fatemeh H Jamebozorgi; Mostafa E Rateb; Ming Du; Mohamed M Abdel-Daim; Guo-Yin Kai; Montaser A M Al-Hammady; Jianbo Xiao; Zhiming Guo; Hesham R El-Seedi
Journal:  Mar Drugs       Date:  2021-04-24       Impact factor: 5.118

5.  Mutational Studies of Putative Biosynthetic Genes for the Cyanobacterial Sunscreen Scytonemin in Nostoc punctiforme ATCC 29133.

Authors:  Daniela Ferreira; Ferran Garcia-Pichel
Journal:  Front Microbiol       Date:  2016-05-18       Impact factor: 5.640

Review 6.  Mycosporine-Like Amino Acids and Their Derivatives as Natural Antioxidants.

Authors:  Naoki Wada; Toshio Sakamoto; Seiichi Matsugo
Journal:  Antioxidants (Basel)       Date:  2015-09-07

7.  Analysis of Mycosporine-Like Amino Acids in Selected Algae and Cyanobacteria by Hydrophilic Interaction Liquid Chromatography and a Novel MAA from the Red Alga Catenella repens.

Authors:  Anja Hartmann; Kathrin Becker; Ulf Karsten; Daniel Remias; Markus Ganzera
Journal:  Mar Drugs       Date:  2015-10-09       Impact factor: 5.118

Review 8.  Uncovering Potential Applications of Cyanobacteria and Algal Metabolites in Biology, Agriculture and Medicine: Current Status and Future Prospects.

Authors:  Rachana Singh; Parul Parihar; Madhulika Singh; Andrzej Bajguz; Jitendra Kumar; Samiksha Singh; Vijay P Singh; Sheo M Prasad
Journal:  Front Microbiol       Date:  2017-04-25       Impact factor: 5.640

Review 9.  Developments of Cyanobacteria for Nano-Marine Drugs: Relevance of Nanoformulations in Cancer Therapies.

Authors:  Vivek K Bajpai; Shruti Shukla; Sung-Min Kang; Seung Kyu Hwang; Xinjie Song; Yun Suk Huh; Young-Kyu Han
Journal:  Mar Drugs       Date:  2018-05-23       Impact factor: 5.118

Review 10.  Advances in the Biotechnological Potential of Brazilian Marine Microalgae and Cyanobacteria.

Authors:  Deborah Terra de Oliveira; Ana Alice Farias da Costa; Fabíola Fernandes Costa; Geraldo Narciso da Rocha Filho; Luís Adriano Santos do Nascimento
Journal:  Molecules       Date:  2020-06-24       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.